SLFN11 Expression and Efficacy of PARP Inhibitor Therapy in Extensive Stage Small Cell Lung Cancer: ECOG-ACRIN 2511 Study

被引:0
|
作者
Owonikoko, T. [1 ]
Dahlberg, S. [2 ]
Sica, G. [3 ]
Poirier, J. [4 ]
Byers, L. [5 ]
Rudin, C. [6 ]
Wistuba, I. [7 ]
Ramalingam, S. [8 ]
机构
[1] Emory Univ, Hematol Med Oncol, Atlanta, GA 30322 USA
[2] Dana Farber Canc Inst, Dept Biostat, Boston, MA 02115 USA
[3] Emory Univ, Pathol, Atlanta, GA 30322 USA
[4] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[5] UT MD Anderson Canc Ctr, Thorac Head & Neck Med Oncol, Houston, TX USA
[6] Mem Sloan Kettering, New York, NY USA
[7] Univ Texas MD Anderson Canc Ctr, Translat Mol Pathol, Houston, TX 77030 USA
[8] Emory Univ, Winship Canc Inst, Med Oncol, Atlanta, GA 30322 USA
关键词
small cell lung cancer; biomarker; SLFN11;
D O I
10.1016/j.jtho.2018.08.1829
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P3.12-06
引用
收藏
页码:S972 / S972
页数:1
相关论文
共 50 条
  • [41] Efficacy and safety of anlotinib as maintenance therapy after induction chemotherapy in extensive-stage small-cell lung cancer
    Wang, Na
    Zhao, Lu
    Zhang, Dou
    Kong, Fanming
    ANTI-CANCER DRUGS, 2023, 34 (04) : 558 - 562
  • [42] Efficacy and safety of CBDCA/ETP/ICI combination therapy for extensive-stage small cell lung cancer in elderly patients
    Fukasawa, Naoto
    Nakamura, Yukiko
    Miyazaki, Kazuhito
    Ikeda, Toshiki
    Higashi, Yuko
    Aga, Masaharu
    Hamakawa, Yusuke
    Taniguchi, Yuri
    Misumi, Yuki
    Agemi, Yoko
    Shimokawa, Tsuneo
    Okamoto, Hiroaki
    ANNALS OF ONCOLOGY, 2023, 34 : S1460 - S1460
  • [43] Efficacy and toxicity of lurbinectedin in subsequent systemic therapy of extensive-stage small cell lung cancer: a meta-analysis
    Tang, Jiayi
    Wang, Tianlei
    Wu, Hongwei
    Bao, Xinrui
    Xu, Ke
    Ren, Tao
    BMC CANCER, 2024, 24 (01)
  • [44] Association Between PD-L1 Expression and Efficacy of Chemoimmunotherapy in Extensive-stage Small Cell Lung Cancer
    Tsuruoka, Kenjiro
    Tamura, Yosuke
    Shimazu, Yasuyuki
    Arai, Masahiro
    Mitsuya, Sho
    Funamoto, Tomoya
    Tsuji, Hiroyuki
    Matsunaga, Ninso
    Nakamura, Takahiko
    Ikeda, Soichiro
    Kawabata, Shigeru
    Imagawa, Akihisa
    Fujisaka, Yasuhito
    ANTICANCER RESEARCH, 2024, 44 (12) : 5531 - 5539
  • [45] The Efficacy and Safety of Anlotinib in Extensive-Stage Small Cell Lung Cancer: A Multicenter Real-World Study
    Zheng, Hao-Ran
    Jiang, Ai-Min
    Gao, Huan
    Liu, Na
    Zheng, Xiao-Qiang
    Fu, Xiao
    Zhang, Rui
    Ruan, Zhi-Ping
    Tian, Tao
    Liang, Xuan
    Yao, Yu
    CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 2273 - 2287
  • [46] Gut microbiota and metabolites associated with immunotherapy efficacy in extensive-stage small cell lung cancer: a pilot study
    Sun, Liyang
    Wang, Xueting
    Zhou, Huimin
    Li, Rui
    Meng, Ming
    Roviello, Giandomenico
    Oh, Byeongsang
    Feng, Lingxin
    Yu, Zhuang
    Wang, Jing
    JOURNAL OF THORACIC DISEASE, 2024, 16 (10) : 6936 - 6954
  • [47] The Retrospective Analysis of Apatinib as Maintenance Therapy in Extensive-Stage Small Cell Lung Cancer
    Yan, X.
    Ma, Z.
    Wang, H.
    Li, P.
    Zheng, X.
    Zhang, G.
    Zhang, M.
    Yang, J.
    Zhang, X.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (09) : S174 - S174
  • [48] Radiation therapy for extensive-stage small-cell lung cancer in the era of immunotherapy
    Tian, Yaru
    Ma, Ji
    Jing, Xuquan
    Zhai, Xiaoyang
    Li, Yuying
    Guo, Zhijun
    Yu, Jinming
    Zhu, Hui
    CANCER LETTERS, 2022, 541
  • [49] Thoracic irradiation as consolidation therapy in patients with extensive-stage small cell lung cancer
    Berta, Judit
    Rozsas, Anita
    Megyesfalvi, Zsolt
    Ostoros, Gyula
    Dome, Balazs
    CURRENT OPINION IN ONCOLOGY, 2023, 35 (01) : 54 - 60
  • [50] Outcomes and Prognostic Factors of Extensive Stage Small Cell Lung Cancer: A Retrospective Study
    Veena, P. S.
    Sajeed, A.
    Geethi, M. H.
    Krishna, K. M. Jagathnath
    Sivananadan, C. D.
    Sankar, S. Arun
    Roshni, S.
    Lijeesh, A. L.
    SOUTH ASIAN JOURNAL OF CANCER, 2023,